Skip to main content

Advertisement

SpringerLink
Log in

Nontuberculous Mycobacterial Lung Infections in Ontario, Canada: Clinical and Microbiological Characteristics

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Study Objectives The aim of this study was to determine gender and clinical phenotype frequencies in pulmonary nontuberculous mycobacterial (NTM) infection and the frequency of disease in NTM isolates. Design The study is a retrospective observational cohort study of two overlapping cohorts: population cohort and clinical cohort. Setting The study was conducted at the University Health Network and Ontario Mycobacteriology Laboratory in Toronto, Ontario, Canada. Patients or Participants The population cohort consisted of all patients with one or more pulmonary NTM isolates in Ontario in 2003. The clinical cohort consisted of all patients with one or more pulmonary NTM isolates at our hospital in 2002–2003. Interventions The study entailed the review of laboratory records and demographics (both cohorts) and detailed clinical records (clinical cohort). Measurements and Results In the population cohort (N = 1651), females comprised 48% overall and 51% with microbiological disease criteria. In the clinical cohort (N = 552), females comprised 48% overall and 55% with NTM disease. In the population cohort, 45% fulfilled microbiological disease criteria, and in the clinical cohort 46% of patients had disease. Patients with MAC isolates fulfilled microbiological disease criteria in 51% of population cohort cases and all disease criteria in 52% of clinical cohort cases. Women more commonly fulfilled microbiological disease criteria in the population cohort (51 vs. 45%, P = 0.02) and all disease criteria in the clinical cohort (53 vs. 40%, P = 0.03). Among clinical cohort patients, 26% (13 women, 44 men) had fibrocavitation, while 62% (101 women, 37 men) had nodular bronchiectasis. Conclusions Women comprised a small majority with disease. Nodular bronchiectasis in women was most common, but significant proportions of each gender with each radiographic type were observed. NTM isolation, particularly MAC, was frequently associated with disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Marras TK, Chedore P, Ying AM, Jamieson F (2007) Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario 1997–2003. Thorax 62:661–666

    Article  PubMed  Google Scholar 

  2. Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, Holland SM, Horsburgh R, Huitt G, Iademarco F, Iseman M, Olivier K, Ruoss S, von Reyn CF, Wallace RJ Jr, Winthrop K (2007) Diagnosis, treatment and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367–416

    Article  CAS  PubMed  Google Scholar 

  3. Prince DS, Peterson DD, Steiner RM, Gottlieb JE, Scott R, Israel HL, Figueroa WG, Fish JE (1989) Infection with Mycobacterium avium complex in patients without predisposing conditions. New Engl J Med 321:863–868

    Article  CAS  PubMed  Google Scholar 

  4. Huang JH, Kao PN, Adi V, Ruoss SJ (1999) Mycobacterium avium-intracellulare pulmonary infection in HIV-negative patients without preexisting lung disease: diagnostic and management limitations. Chest 115:1033–1040

    Article  CAS  PubMed  Google Scholar 

  5. Hanna BA, Ebrahimzadeh A, Elliott LB, Morgan MA, Novak SM, Rusch-Gerdes S, Acio M, Dunbar DF, Holmes TM, Rexer CH, Savthyakumar C, Vannier AM (1999) Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol 37:748–752

    CAS  PubMed  Google Scholar 

  6. Butler WR, Guthertz LS (2001) Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev 14:704–726

    Article  CAS  PubMed  Google Scholar 

  7. Arnow PM, Bakir M, Thompson K, Bova JL (2000) Endemic contamination of clinical specimens by Mycobacterium gordonae. Clin Infect Dis 31:472–476

    Article  CAS  PubMed  Google Scholar 

  8. Kim RD, Greenberg DE, Ehrmantraut ME, Guide SV, Ding L, Shea Y, Brown MR, Chernick M, Steagall WK, Glasgow CG, Lin JP, Jolley C, Sorbara L, Raffeld M, Hill S, Avila N, Sachdev V, Barnhart LA, Anderson VL, Claypool L, Hilligoss DM, Garofalo M, Fitzgerald A, Anaya-O’Brien S, Darnell D, DeCastro R, Menning HM, Ricklefs SM, Porcella SF, Olivier KN, Moss J, Holland SM (2008) Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome. Am J Respir Crit Care Med 178:1066–1074

    Article  CAS  PubMed  Google Scholar 

  9. Fogan L (1970) Atypical mycobacteria. Medicine 49:243–255

    Article  CAS  PubMed  Google Scholar 

  10. Ahn CH, Lowell JR, Onstad GD, Shuford EH, Hurst GA (1979) A demographic study of disease due to Mycobacterium kansasii or M intracellulare-avium in Texas. Chest 75:120–125

    Article  CAS  PubMed  Google Scholar 

  11. O’Brien RJ, Geiter LJ, Snider DE Jr (1987) The epidemiology of nontuberculous mycobacterial diseases in the United States. Results from a national survey. Am Rev Respir Dis 135:1007–1014

    PubMed  Google Scholar 

  12. Butler W, Crawford J, Shutt K (1999) Nontuberculous mycobacteria reported to the Public Health Laboratory Information System by state public health laboratories, United States, 1993–1996. Centers for Disease Control and Prevention, Atlanta.

  13. Donnabella V, Salazar-Schicchi J, Bonk S, Hanna B, Rom WN (2000) Increasing incidence of Mycobacterium xenopi at Bellevue Hospital: an emerging pathogen or a product of improved laboratory methods? Chest 118:1365–1370

    Article  CAS  PubMed  Google Scholar 

  14. Gale GL (1976) Atypical mycobacteria in a tuberculosis hospital. Can Med Assoc J 114:612–614

    CAS  PubMed  Google Scholar 

  15. Warring FC Jr (1968) Mycobacteria in a New England Hospital. Am Rev Respir Dis 98:965–977

    PubMed  Google Scholar 

  16. Gorse GJ, Fairshter RD, Friedly G, Dela Maza L, Greene GR, Cesario TC (1983) Nontuberculous mycobacterial disease: experience in a Southern California hospital. Arch Intern Med 143:225–228

    Article  CAS  PubMed  Google Scholar 

  17. Reich JM, Johnson RE (1991) Mycobacterium avium complex pulmonary disease: incidence, presentation, and response to therapy in a community setting. Am Rev Respir Dis 143:1381–1385

    CAS  PubMed  Google Scholar 

  18. Bodle EE, Cunningham JA, Della-Latta P, Schluger N, Saiman L (2008) Epidemiology of nontuberculous mycobacteria in patients without HIV infection, New York City. Emerg Infect Dis 14:390–396

    Article  PubMed  Google Scholar 

  19. Cassidy PM, Hedberg K, Saulson A, McNelly E, Winthrop KL (2009) Nontuberculous mycobacterial disease prevalence and risk factors: a changing epidemiology. Clin Infect Dis 49(12):e124–e129

    Article  PubMed  Google Scholar 

  20. Jenkins PA (1981) The epidemiology of opportunist mycobacterial infections in Wales, 1952–1978. Rev Infect Dis 3:1021–1023

    CAS  PubMed  Google Scholar 

  21. Gerogianni I, Papala M, Kostikas K, Petinaki E, Gourgoulianis KI (2008) Epidemiology and clinical significance of mycobacterial respiratory infections in Central Greece. Int J Tuberc Lung Dis 12:807–812

    CAS  PubMed  Google Scholar 

  22. Van Ingen J, Bendien SA, de Lange WCM, Hoefsloot W, Dekhuijzen PNR, Boeree MJ, van Soolingen D (2009) Clinical relevance of nontuberculous mycobacteria isolated in Nijmegen-Arnhem region, The Netherlands. Thorax 64:502–506

    Article  PubMed  Google Scholar 

  23. Kubin M, Svandova E, Medek B, Chobot S, Olsovsky Z (1980) Mycobacterium kansasii infection in an endemic area of Czechoslovakia. Tubercle 61:207–212

    Article  CAS  PubMed  Google Scholar 

  24. Kaustova J, Chmelik M, Ettlova D, Hudec V, Lazarova H, Richtrova S (1995) Disease due to Mycobacterium kansasii in the Czech Republic: 1984–1989. Tuber Lung Dis 76:205–209

    Article  CAS  PubMed  Google Scholar 

  25. Leal Arranz MV, Gaafar A, Unzaga Barañano MJ, Crespo Notario JA, Cisterna Cáncer R, Garcia Cebrián F (2005) Clinical and epidemiological study of disease caused by Mycobacterium kansasii in the metropolitan area of Bilbao, Spain. Arch Bronconeumol 41:189–196

    CAS  PubMed  Google Scholar 

  26. Van Ingen J, Boeree MJ, de Lange WCM, Hoefsloot W, Bendien SA, Magis-Escurra C, Dekhuijzen PNR, van Soolingen D (2008) Mycobacterium xenopi clinical relevance and determinants, the Netherlands. Emerg Infect Dis 14:385–389

    Article  PubMed  Google Scholar 

  27. Marusic A, Katalinic-Jankovic V, Popovic-Grle S, Jankovic M, Mazuranic I, Puljic I, Seric Milic H (2009) Mycobacterium xenopi pulmonary disease—epidemiology and clinical features in non-immunocompromised patients. J Infect 58:108–112

    Article  PubMed  Google Scholar 

  28. Dailloux M, Abalain ML, Laurain C, Lebrun L, Loos-Ayav C, Lozniewski A, Maugein J (2006) Respiratory infections associated with nontuberculous mycobacteria in non-HIV patients. Eur Respir J 28:1211–1215

    Article  CAS  PubMed  Google Scholar 

  29. Tsukamura M, Kita N, Shimoide H, Arakawa H, Kuze A (1988) Studies on the epidemiology of nontuberculous mycobacteriosis in Japan. Am Rev Respir Dis 137:1280–1284

    CAS  PubMed  Google Scholar 

  30. Hosker HSR, Lam CW, Ng TK, Ma HK, Chan SL (1995) The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 89:3–8

    Article  CAS  PubMed  Google Scholar 

  31. Shih JY, Hsueh PR, Lee LN, Wang HC, Yang PC, Kuo SH, Luh KT (1997) Nontuberculous mycobacteria isolates: clinical significance and disease spectrum. J Formos Med Assoc 96:621–626

    CAS  PubMed  Google Scholar 

  32. Koh WJ, Kwon OJ, Jeon K, Kim TS, Lee KS, Park YK, Bai GH (2006) Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest 129:341–348

    Article  PubMed  Google Scholar 

  33. Okumura M, Iwai K, Ogata H, Ueyama M, Kubota M, Aoki M, Kokuto H, Tadokoro E, Uchiyama T, Saotome M, Yoshiyama T, Yoshimori K, Yoshida N, Azuma A, Kudoh S (2008) Clinical factors on cavitary and nodular bronchiectatic types in pulmonary Mycobacterium avium complex disease. Intern Med 47:1465–1472

    Article  PubMed  Google Scholar 

  34. O’Brien DP, Currie BJ, Krause VL (2000) Nontuberculous mycobacterial disease in Northern Australia: a case series and review of the literature. Clin Infect Dis 31:958–968

    Article  PubMed  Google Scholar 

  35. Freeman J, Morris A, Blackmore T, Hammer D, Munroe S, McKnight L (2007) Incidence of nontuberculous mycobacterial disease in New Zealand, 2004. N Z Med J 120(1256):U2580

    PubMed  Google Scholar 

  36. Khan K, Wang J, Marras TK (2007) Nontuberculous mycobacterial sensitization in the United States: national trends over three decades. Am J Respir Crit Care Med 176:306–313

    Article  PubMed  Google Scholar 

  37. Reich JM, Johnson RE (1992) Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern: the Lady Windermere Syndrome. Chest 101:1605–1609

    Article  CAS  PubMed  Google Scholar 

  38. Choudhri S, Manfreda J, Wolfe J, Parker S, Long R (1995) Clinical significance of nontuberculous mycobacteria isolates in a Canadian tertiary care center. Clin Infect Dis 21:128–133

    CAS  PubMed  Google Scholar 

  39. Robinson BL, Grzybowski S, Bowmer EJ, McDiarmid J, Whittaker EI, Tanner K (1969) Atypical mycobacterial disease in British Columbia, 1960–1967. Can Med Assoc J 101:17–24

    CAS  PubMed  Google Scholar 

  40. Schaefer WB, Birn KJ, Jenkins PA, Marks J (1969) Infection with the avian-Battey group of mycobacteria in England and Wales. Br Med J 2:412–415

    Article  CAS  PubMed  Google Scholar 

  41. Marras TK, Daley CL (2002) Epidemiology of human pulmonary infection with nontuberculous mycobacteria. Clin Chest Med 23:553–567

    Article  PubMed  Google Scholar 

  42. Varadi RG, Marras TK (2009) Pulmonary Mycobacterium xenopi infection in non-HIV-infected patients: a systematic review. Int J Tuberc Lung Dis 13:1210–1218

    CAS  PubMed  Google Scholar 

  43. Han XY, Tarrand JT, Infante R, Jacobson KL, Truong M (2005) Clinical significance and epidemiologic amalyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol 43:4407–4412

    Article  PubMed  Google Scholar 

  44. Maesaki S, Kohno S, Koga H, Miyazaki Y, Kaku M (1993) A clinical comparison between Mycobacterium avium and Mycobacterium intracellulare. Chest 104:1408–1411

    Article  CAS  PubMed  Google Scholar 

  45. Toyoda T, Aoyagi T, Saito H (1993) Clinical features of the lung diseases due to Mycobacterium avium and M. intracellulare. Kekkaku 68:63–69

    CAS  PubMed  Google Scholar 

  46. Tortoli E, Rindi L, Garcia MJ, Chiaradonna P, Dei R, Garzelli C, Kroppenstedt RM, Lari N, Mattei R, Mariottini A, Mazzarelli G, Murcia MI, Nanetti A, Piccoli P, Scarparo C (2004) Proposal to elevate the genetic variant MAC-A, included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol 54:1277–1285

    Article  CAS  PubMed  Google Scholar 

  47. Turenne CY, Thibert L, Williams K, Burdz TV, Cook VJ, Wolfe JN, Cockcroft DW, Kabani A (2004) Mycobacterium saskatchewanense sp. nov., a novel slowly growing scotochromogenic species from human clinical isolates related to Mycobacterium interjectum and Accuprobe positive for Mycobacterium avium complex. Int J Syst Evol Microbiol 54:659–667

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

We are grateful to Dr. Kevin Winthrop, who provided thoughtful commentary regarding estimating the fraction of patients who have NTM disease based on the presence of microbiology criteria.

Author information

Authors and Affiliations

  1. Joint Division of Respirology, Department of Medicine, University of Toronto, University Health Network and Mount Sinai Hospital, Toronto, Canada

    Theodore K. Marras & Mauli Mehta

  2. TB and Mycobacteriology Laboratory, Public Health Laboratory - Toronto, Ontario Agency for Health Protection and Promotion, Toronto, ON, Canada

    Pamela Chedore & Kevin May

  3. University of Toronto, Toronto, Canada

    Mohammed Al Houqani

  4. Public Health Laboratory, Ontario Agency for Health Protection and Promotion, and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada

    Frances Jamieson

  5. Toronto Western Hospital, 7E-452, 399 Bathurst Street, Toronto, ON, M5T 2S8, Canada

    Theodore K. Marras

Authors
  1. Theodore K. Marras
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mauli Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pamela Chedore
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kevin May
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Mohammed Al Houqani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Frances Jamieson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Theodore K. Marras.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marras, T.K., Mehta, M., Chedore, P. et al. Nontuberculous Mycobacterial Lung Infections in Ontario, Canada: Clinical and Microbiological Characteristics. Lung 188, 289–299 (2010). https://doi.org/10.1007/s00408-010-9241-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-010-9241-8

Keywords

Search

Navigation